TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Adesso BioProducts AB
Closing information (x1000 EUR)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 245,136 | 244,644 | 190,309 |
Financial expenses | 990 | 1,092 | 1,138 |
Earnings before taxes | 15,070 | 17,084 | 9,645 |
EBITDA | 16,161 | 18,318 | 10,974 |
Total assets | 81,099 | 80,338 | 54,703 |
Current assets | 79,501 | 78,590 | 52,915 |
Current liabilities | 29,166 | 36,021 | 22,554 |
Equity capital | 39,837 | 31,155 | 18,740 |
- share capital | 9 | 10 | 10 |
Employees (average) | 21 | 21 | 20 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 49.1% | 38.8% | 34.3% |
Turnover per employee | 11,673 | 11,650 | 9,515 |
Profit as a percentage of turnover | 6.1% | 7.0% | 5.1% |
Return on assets (ROA) | 19.8% | 22.6% | 19.7% |
Current ratio | 272.6% | 218.2% | 234.6% |
Return on equity (ROE) | 37.8% | 54.8% | 51.5% |
Change turnover | 20,308 | 57,859 | -10,702 |
Change turnover % | 9% | 31% | -5% |
Chg. No. of employees | 0 | 1 | 2 |
Chg. No. of employees % | 0% | 5% | 11% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.